A new direct-visualization technology is aiding doctors in the diagnosis of tumors in the pancreas and bile ducts, without the need for invasive surgery. Called SpyGlass™, the scope-type technology allows doctors to enter and look directly into the pancreas and bile duct system to determine the cause of blockages or disease, and obtain tissue samples for biopsy.
“This new device is going to increase early diagnosis of pancreatic diseases and cancer,” said Adam B. Elfant, M.D., Director of Therapeutic Endoscopy at the Cooper Digestive Health Institute. “The ability to finally biopsy difficult-to-reach areas within the ductal system and pancreas will allow patients to be treated sooner if cancer is found, leading to better outcomes for patients. This is a remarkable step in diagnosis for this devastating cancer,” Dr. Elfant said.
Cooper is the only center in South Jersey that offers the SpyGlass™ system.
